Stock Markets
Daily Stock Markets News

Stocks to watch: HPCL, Colgate, Pfizer, ACC, Kansai Nerolac, BEL, Arvind


Colgate Palmolive India: The company reported a consolidated net profit of 364 crore for the June quarter in FY25, a 33% growth from 273.68 crore in the same quarter of the previous year. Net sales rose 13% to 1,485.8 crore from 1,314.7 crore, with rural market demand outpacing urban growth for the second consecutive quarter. Domestic revenues grew 12.8% YoY driven by toothpaste, toothbrush, and personal care. EBITDA margins remained consistent despite a 10% increase in advertising spend.

Tata Consumer Products: The company is set to report its Q1FY25 earnings on 30 July, with expected revenues of 4,293 crore, up 14% YoY, and net profit likely at 335 crore, up 4% YoY. Domestic tea, salts, and NourishCo products are expected to outperform, while India Foods segment is expected to grow 13% YoY with 9% volume growth. The international business is expected to grow 11% YoY, driven by stable volumes and pricing. Analysts will monitor demand in metro areas and tier-3 towns, tea and coffee prices, and the impact of raw material pricing on margins.

Get Quick Cash in Minutes!

Best Personal Loan at Lowest Interest Rates

Instant Apply

Hindustan Petroleum Corporation: HPCL reported a consolidated net profit of 633.94 crore for Q1FY25, a 90.6% decline from 6,765.50 crore in the same period last year. Net profit declined 76% sequentially from 2,709.31 crore in the March quarter, while total income remained flat at 1.21 lakh crore. The average gross refining margin (GRM) for Q1 was $5.03 per barrel, down from $7.44 last year, and throughput was 5.76 million metric tonnes (MMT), up from 5.40 MMT last year. Domestic sales were 12.07 MMT, up from 11.43 MMT. Exports were 0.56 MMT. HPCL invested 2,017 crore to strengthen refining and marketing infrastructure, commissioned 126 retail outlets and nine new LPG distributorships.

Pfizer: The drugmaker reported a 61.2% YoY jump in net profit at 150.7 crore for Q1FY25, up from 94 crore. Revenue from operations increased 5.9% to 563 crore from 531.4 crore. EBITDA jumped 60.2% to 177.5 crore from 110.8 crore. EBITDA margin stood at 31.5%, up from 20.9%.

Jindal Saw: The company reported a 66.7% YoY jump in net profit at 441.1 crore for Q1FY25, up from 265 crore. Revenue from operations increased 12% to 4,939 crore from 4,410 crore. EBITDA jumped 38.2% to 839.6 crore from 607.7 crore. EBITDA margin stood at 17%, up from 13.8%. The company’s current order book stood at 165 crore, up from 153 crore. Large demand in the water sector led to the sale of 55,000 MT rust-free pipes. Order book for the south division was 245,000 MT.

ACC: The Adani Group company reported a consolidated profit after tax of 361 crore for Q1FY25, down 22.5% from 466 crore. Revenue from operations slipped to 5,154.89 crore from 5,201.11 crore. Q1 operating EBITDA was 679 crore with a margin of 13.2%. Operating cost improved by 7% YoY. Cash and cash equivalent at 2,747 crore.

Novartis India: The company reported net sales of 92.29 crore for June 2024, up 1.87% YoY. Net profit rose 27.05% to 25.74 crore. EBITDA increased 15.41% to 34.38 crore. EPS increased to 10.42. Shares closed at 1,156.00 on July 26, 2024.

Kansai Nerolac Paints: The company’s net profit fell 69% YoY to 231 crore for Q1FY25, down from 738 crore. Revenue from operations declined 11% to 2,133 crore from 2,157 crore. EBITDA fell 0.7% to 329.5 crore. EBITDA margin remained at 15.4%. Demand for automotive coatings was strong, while decorative and performance coatings were subdued. Raw material prices had started to harden. The company also appointed Hirokazu Kotera as a whole-time director.

Indian Bank: The bank reported a 40.6% YoY rise in net profit at 2,403.42 crore for Q1FY25, up 7% sequentially. Net NPA ratio eased to 0.39% from 0.43%…



Read More: Stocks to watch: HPCL, Colgate, Pfizer, ACC, Kansai Nerolac, BEL, Arvind

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.